Market Research Industry Reports

Rheumatoid Arthritis (RA) - Dynamic Market Forecast to 2025

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Rheumatoid Arthritis (RA) - Dynamic Market Forecast to 2025

Summary

Rheumatoid Arthritis (RA) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the RA space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact the projected market forecast.

Scope

Key events covered in the Dynamic Market Forecast include -
- Regulatory filings
- Approval decisions
- Pricing changes
- Patent litigation
- Clinical trial data announcements
- Clinical trial failures
- Clinical trial timeline updates

Components of the slide deck include -
- Timeline of market-impacting events
- Key clinical trial landscape updates
- Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
- Overview of updates to the forecast model based on anticipated future impact of events
- Forward-looking events calendar listing expected key updates to the RA competitive space through June 2018

Reasons to buy

- Recent Regulatory Events
- Recent Commercial Events
- Recent Clinical Events
- Market Dynamics Shifts Towards Biosimilars in the RA Setting
- Discontinuation of J&Js Sirukumab for RA Creates Opportunity for Other IL-6 Inhibitors
- Increased Competition Among the Oral JAK Inhibitors in the RA Setting
1. Dynamic Market Forecast Overview 5
1.1 Related Reports 6
1.2 Upcoming Related Reports 7
2. Executive Summary 8
2.1 Key Updates to RA Market Dynamics 9
2.1 Key Events in Update 10-12
2.2 Clinical Trial Landscape Updates 13
2.3 Pipeline Landscape Updates 14
2.4 Market Insight on Key Events 15
3. Event 1: Market Dynamics Shift Towards Biosimilars 16
3.1 Key Updates to Biosimilar Market Dynamics 17
3.2 Enbrel Biosimilars 18
3.3 Humira Biosimilars 19
3.4 Remicade Biosimilars 20
3.5 Rituxan Biosimilars 21
3.6 What Do Physicians Think? 22
3.7 Summary/Trends 23
3.8 Sources 24
4. Event 2: Discontinuation of Sirukumab Creates Opportunity for Other IL-6 Inhibitors 25
4.1 Key Updates to the Anti-IL-6 Market Dynamics 26
4.2 J&J, sirukumab 27
4.3 Regeneron/Sanofi, Kevzara (sarilumab) 28
4.4 What Do Physicians Think? 29
4.5 Summary/Trends 30
4.6 Sources 31
5. Event 3: Competition Among the Oral JAK Inhibitors 32
5.1 Key Updates to the JAK Inhibitor Market Dynamics 33
5.2 Eli Lilly, Olumiant (baricitinib) 34-35
5.3 AbbVie, upadacitinib 36
5.4 What Do Physicians Think? 37
5.5 Summary/Trends 38
5.6 Sources 39
6. Events Calendar 40
6.1 Key Events Expected to Occur H1 2018 41
7. Appendix 42
7.1 Methodology 43
7.2 Primary Research 44-45
7.3 About the Authors 46-48
7.4 About GlobalData 49
7.5 Contact Us 50
7.6 Disclaimer 51

Rheumatoid Arthritis - Pipeline Review, H1 2018

Rheumatoid Arthritis - Pipeline Review, H1 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2018, provides an overview of the Rheumatoid Arthritis

USD 2500View Report

Global Rheumatoid Arthritis Therapeutics Market Research Report 2018

Rheumatoid Arthritis Therapeutics Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on

USD 2850View Report

Rheumatoid Arthritis - Pipeline Review, H1 2018

Rheumatoid Arthritis - Pipeline Review, H1 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2018, provides an overview of the Rheumatoid Arthritis

USD 2500View Report

Global Rheumatoid Arthritis Therapeutics Market Research Report 2018

Rheumatoid Arthritis Therapeutics Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on

USD 2850View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 8495
  • Site Licence    USD 16990
  • Enterprise Wide Licence    USD 25485
$ 8495

Reports Details

Published Date : Nov 2017
No. of Pages :51
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube